Aerovate Newsroom

Aerovate Therapeutics Analyst Ratings

BenzingaJun 17 13:08 ET

Wedbush Downgrades Aerovate Therapeutics to Neutral From Outperform, Adjusts Price Target to $3 From $41

MT NewswiresJun 17 09:36 ET

Aerovate Therapeutics Analyst Ratings

BenzingaJun 6 09:54 ET

Jefferies Sticks to Its Buy Rating for Aerovate Therapeutics (AVTE)

TipRanksMay 28 08:17 ET

Aerovate Therapeutics Analyst Ratings

BenzingaMay 22 10:59 ET

Analysts Are Bullish on These Healthcare Stocks: AbbVie (ABBV), Aerovate Therapeutics (AVTE)

TipRanksMay 22 05:55 ET

Aerovate Therapeutics Analyst Ratings

BenzingaMay 14 08:34 ET

Wedbush Remains a Buy on Aerovate Therapeutics (AVTE)

TipRanksMay 14 08:03 ET

Aerovate Therapeutics Analyst Ratings

BenzingaApr 1 12:06 ET

Analysts Offer Insights on Healthcare Companies: Healthequity (HQY), Aerovate Therapeutics (AVTE) and Delcath Systems (DCTH)

TipRanksMar 27 06:15 ET

Aerovate Therapeutics Analyst Ratings

BenzingaMar 25 08:40 ET

TD Cowen Sticks to Its Buy Rating for Aerovate Therapeutics (AVTE)

TipRanksFeb 26 07:36 ET

Aerovate Therapeutics (AVTE) Receives a Buy From BTIG

TipRanksJan 2 09:08 ET

Buy Rating Affirmed: Aerovate Therapeutics' AV-101 Shows Strong Potential Amid Successful IMPAHCT Trial Progression

TipRanksNov 27, 2023 11:35 ET

Analysts' Top Healthcare Picks: Aerovate Therapeutics (AVTE), Calidi Biotherapeutics (CLDI)

TipRanksNov 22, 2023 06:20 ET

Analysts Offer Insights on Healthcare Companies: Adicet Bio (ACET) and Aerovate Therapeutics (AVTE)

TipRanksNov 14, 2023 01:50 ET

TD Cowen Sticks to Their Buy Rating for Aerovate Therapeutics (AVTE)

TipRanksNov 13, 2023 10:16 ET

Wedbush Adjusts Aerovate Therapeutics Price Target to $48 From $50, Maintains Outperform Rating

MT NewswiresAug 15, 2023 11:04 ET

Analysts Are Bullish on Top Healthcare Stocks: Aerovate Therapeutics (AVTE), Antibe Therapeutics (ATBPF)

TipRanksAug 15, 2023 10:30 ET

Aerovate Therapeutics (AVTE) Gets a Buy From Jefferies

TipRanksAug 15, 2023 09:05 ET